Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
The new subsidiary company shall be engaged in systems and solutions for avionic applications, manufacturing, testing, repair and overhauling systems for defence and aerospace platforms.
The new subsidiary will be setting up State-of-the-Art Advanced Heterogeneous Packaging and 3D Packaging OSAT (Outsourced Semiconductor Assembly and Testing), with a focus on AI, High Performance Computing (HPC), Networking, and Data Center Applications.
Paras Defence and Space Technologies is primarily engaged in the designing, developing, manufacturing, and testing of a variety of defence and space engineering products and solutions. The company caters to four major segments - defence & space optics, defence electronics, heavy engineering, and electromagnetic pulse protection solutions.
The company reported a 48.9% jump in consolidated net profit to Rs 20.64 crore on 21.4% increase in revenue from operations to Rs 105.72 crore in Q2 FY26 over Q2 FY25.
SAIL & Sammaan Capital shares are banned from F&O on 25 November 2025.
Stocks to Watch:
Surya Roshini has received the order for the supply of spiral pipes with external 3 LPE coating, valued at Rs 105.18 crore, to be executed by 31 March 2026.
Eris Lifesciencesl board approved acquiring remaining 30% stake in Swiss Parenterals (Swiss) for Rs 423.3 crore via share-swap. The deal makes Swiss a 100% subsidiary
Paras Defence and Space Technologies has signed a memorandum of association (MoU) with Inter-University Accelerator Centre (IUAC), New Delhi to develop commercial- grade MRI magnet system for indigenous manufacturing in the country to make India a Self-Reliant in superconducting MRI Magnet technology.
Housing & Urban Development Corporation (Hudco) has signed memorandum of understanding (MoU) with Naional Institute of Urban Affairs (NIUA) to explore collaborations with multi-lateral funding agencies and other suitable financing opportunities.
Ceigall India has received a letter of intent (LoI) from REC Power Development Consultancy (PDCL) to establish Velgaon Substation. The consideration of said order is Rs 58.5 crore annually for 35 years.
Dr Reddy’s Laboratories announced that the European Commission (EC) has granted marketing authorization for AVT03, a biosimilar of Prolia (denosumab) and Xgeva (denosumab).
Under the MoU, Paras Defence and IUAC will jointly develop a commercial-grade MRI magnet system. The collaboration aims to enable indigenous manufacturing of superconducting MRI magnet technology. The companies said the project supports India’s push toward self-reliance under Aatma Nirbhar Bharat.
Inter- University Accelerator Centre (IUAC), New-Delhi is an autonomous Institute under the University Grants Commission (UGC), Ministry of Education (MoE), Government of India (GOI), and carries out particle accelerator based basic research and development.
PARAS and IUAC will combine their respective capabilities in order to develop commercial- grade MRI magnet system for indigenous manufacturing in the country to make India a Self-Reliant in superconducting MRI Magnet technology, thus nurturing Aatma Nirbhar Bharat.